PegBio Co., Ltd. (the “Company”) disclosed that Yizekangrui Medical (HK) Limited, a cornerstone investor holding 9,584,500 H shares (approximately 3.43% of the total issued H shares), has voluntarily extended its lock-up period for these shares. The original lock-up was set to expire on November 26, 2025; it will now remain in effect until December 31, 2025.

According to the announcement, the Company believes this extension signals the cornerstone investor’s confidence in its research and development capabilities and progress toward clinical milestones. As stated in the document, the investor will continue reviewing the Company’s performance and may consider further extensions based on real-time developments.

Shareholders and potential investors are advised to exercise caution when dealing in the Company’s securities.